AORT (Artivion) Other Current Liabilities: $38.0 Mil (As of Mar. 2026)


AORT Artivion Inc AORT
81 GF Score
Price $24.09
GF Value $28.42
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Artivion Other Current Liabilities?

Artivion AORT -0.08% 81 Other Current Liabilities is $38.0 Mil as of Mar. 2026. GuruFocus rates AORT with a GF Score™ of 81/100 and a GF Value™ of $28.42 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Artivion's other current liabilities for the quarter that ended in Mar. 2026 was $38.0 Mil.

Artivion's quarterly other current liabilities increased from Sep. 2025 ($40.7 Mil) to Dec. 2025 ($48.0 Mil) but then declined from Dec. 2025 ($48.0 Mil) to Mar. 2026 ($38.0 Mil).

Artivion's annual other current liabilities declined from Dec. 2023 ($21.1 Mil) to Dec. 2024 ($18.9 Mil) but then increased from Dec. 2024 ($18.9 Mil) to Dec. 2025 ($48.0 Mil).

Artivion Other Current Liabilities Related Terms

Artivion Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Artivion's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Artivion Other Current Liabilities Chart

Artivion Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.24 15.12 21.11 18.93 47.95

Artivion Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.00 19.00 40.67 47.95 38.01
AORT
81GF Score
Artivion Inc AORT
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Artivion Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $38.0 Mil mean?
Artivion (AORT) has a Other Current Liabilities of $38.0 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Artivion.
Is Artivion's Other Current Liabilities too high?
Artivion's current Other Current Liabilities is $38.0 Mil. Overall, Artivion has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Artivion's Other Current Liabilities compare to LMRI and AVNS?
Artivion's Other Current Liabilities of $38.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Artivion. Artivion's current Other Current Liabilities is $38.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artivion stock overvalued right now?
Based on GuruFocus' analysis, Artivion (AORT) is currently considered Modestly Undervalued. The stock's GF Value™ is $28.42, compared to a current price of $24.09 — trading 15.2% below its estimated fair value. The current Other Current Liabilities is $38.0 Mil. Artivion's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Artivion (AORT), the current Other Current Liabilities is $38.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Artivion (AORT) Overvalued in 2026?

Based on GuruFocus' analysis, Artivion stock appears to be undervalued. The current stock price of $24.09 is trading 15.2% below its estimated GF Value™ of $28.42. GuruFocus considers Artivion to be Modestly Undervalued.

Key valuation signals for AORT:

  • Other Current Liabilities: $38.0 Mil
  • GF Value™: $28.42 vs. price of $24.09 (15.2% below fair value)
  • GF Score™: 81/100 with 5 warning signs

No single metric tells the full story. See the AORT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Artivion Business Description

Other Exchanges CYL:Germany
Address 1655 Roberts Boulevard North West, Kennesaw, GA, USA, 30144
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
81GF Score

Get the complete analysis for AORT

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$24.09
Price
$28.42
GF Value